Proteomics-Driven Biomarkers in Pancreatic Cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Outros |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/158794 |
Resumo: | Publisher Copyright: © 2023 by the authors. |
id |
RCAP_86bf69e07ae66e16733abe7eafad3e00 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/158794 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Proteomics-Driven Biomarkers in Pancreatic Cancerbiomarkerchemotherapy effectivenesspancreatic cancerproteomicsStructural BiologyBiochemistryMolecular BiologyClinical BiochemistrySDG 3 - Good Health and Well-beingPublisher Copyright: © 2023 by the authors.Pancreatic cancer is a devastating disease that has a grim prognosis, highlighting the need for improved screening, diagnosis, and treatment strategies. Currently, the sole biomarker for pancreatic ductal adenocarcinoma (PDAC) authorized by the U.S. Food and Drug Administration is CA 19-9, which proves to be the most beneficial in tracking treatment response rather than in early detection. In recent years, proteomics has emerged as a powerful tool for advancing our understanding of pancreatic cancer biology and identifying potential biomarkers and therapeutic targets. This review aims to offer a comprehensive survey of proteomics’ current status in pancreatic cancer research, specifically accentuating its applications and its potential to drastically enhance screening, diagnosis, and treatment response. With respect to screening and diagnostic precision, proteomics carries the capacity to augment the sensitivity and specificity of extant screening and diagnostic methodologies. Nonetheless, more research is imperative for validating potential biomarkers and establishing standard procedures for sample preparation and data analysis. Furthermore, proteomics presents opportunities for unveiling new biomarkers and therapeutic targets, as well as fostering the development of personalized treatment strategies based on protein expression patterns associated with treatment response. In conclusion, proteomics holds great promise for advancing our understanding of pancreatic cancer biology and improving patient outcomes. It is essential to maintain momentum in investment and innovation in this arena to unearth more groundbreaking discoveries and transmute them into practical diagnostic and therapeutic strategies in the clinical context.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)iNOVA4Health - pólo NMSComprehensive Health Research Centre (CHRC) - pólo NMSRUNRamalhete, LuísVigia, EmanuelAraújo, RúbenPinto Marques, Hugo2023-10-09T22:18:37Z2023-092023-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttp://hdl.handle.net/10362/158794eng2227-7382PURE: 73492450https://doi.org/10.3390/proteomes11030024info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:14:59Zoai:run.unl.pt:10362/158794Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:14:59Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
title |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
spellingShingle |
Proteomics-Driven Biomarkers in Pancreatic Cancer Ramalhete, Luís biomarker chemotherapy effectiveness pancreatic cancer proteomics Structural Biology Biochemistry Molecular Biology Clinical Biochemistry SDG 3 - Good Health and Well-being |
title_short |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
title_full |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
title_fullStr |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
title_full_unstemmed |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
title_sort |
Proteomics-Driven Biomarkers in Pancreatic Cancer |
author |
Ramalhete, Luís |
author_facet |
Ramalhete, Luís Vigia, Emanuel Araújo, Rúben Pinto Marques, Hugo |
author_role |
author |
author2 |
Vigia, Emanuel Araújo, Rúben Pinto Marques, Hugo |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) iNOVA4Health - pólo NMS Comprehensive Health Research Centre (CHRC) - pólo NMS RUN |
dc.contributor.author.fl_str_mv |
Ramalhete, Luís Vigia, Emanuel Araújo, Rúben Pinto Marques, Hugo |
dc.subject.por.fl_str_mv |
biomarker chemotherapy effectiveness pancreatic cancer proteomics Structural Biology Biochemistry Molecular Biology Clinical Biochemistry SDG 3 - Good Health and Well-being |
topic |
biomarker chemotherapy effectiveness pancreatic cancer proteomics Structural Biology Biochemistry Molecular Biology Clinical Biochemistry SDG 3 - Good Health and Well-being |
description |
Publisher Copyright: © 2023 by the authors. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-10-09T22:18:37Z 2023-09 2023-09-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/other |
format |
other |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/158794 |
url |
http://hdl.handle.net/10362/158794 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2227-7382 PURE: 73492450 https://doi.org/10.3390/proteomes11030024 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545960348188672 |